56 related articles for article (PubMed ID: 3051599)
1. Rejection treatment by polyclonal antibodies in kidney transplantation: reliable therapy without severe side effects.
Greger B; Reis HJ; Mellert J; Schareck WD; Müller GH; Hopt UT; Bockhorn H
Transplant Proc; 1988 Oct; 20(5 Suppl 6):9-11. PubMed ID: 3051599
[No Abstract] [Full Text] [Related]
2. Induction antibody therapy in kidney transplantation.
Padiyar A; Augustine JJ; Hricik DE
Am J Kidney Dis; 2009 Nov; 54(5):935-44. PubMed ID: 19682780
[TBL] [Abstract][Full Text] [Related]
3. Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation.
Birkeland SA; Svendsen V; Rohr N; Hansen BL; Elbirk A; Foged N; Køhler F
Transplant Proc; 1988 Jun; 20(3):451-4. PubMed ID: 3289183
[No Abstract] [Full Text] [Related]
4. Monoclonal antibodies for kidney allograft rejection.
Med Lett Drugs Ther; 1986 Oct; 28(724):97-8. PubMed ID: 3531791
[No Abstract] [Full Text] [Related]
5. Antirejection treatment in kidney transplantation--is there a proved rationale for the general use of monoclonal antibodies?
Reis HJ; Hopt UT; Greger B; Schareck WD; Bockhorn H
Transplant Proc; 1987 Oct; 19(5):3565-9. PubMed ID: 2823424
[No Abstract] [Full Text] [Related]
6. Nonsteroid treatment of rejection in kidney transplantation. A new approach including long-term treatment of rejection with antilymphoblast globulin in a high risk population.
Toledo-Pereyra LH; Mittal VK; Baskin S; McNichol LJ; Whitten JI
Transplantation; 1982 Mar; 33(3):325-7. PubMed ID: 6801834
[No Abstract] [Full Text] [Related]
7. Evolution of chronic antibody mediated-rejection: a case report.
Cornell LD; Wong W; Saidman S; Collins AB; Colvin RB
Clin Transpl; 2006; ():463-7. PubMed ID: 18365404
[No Abstract] [Full Text] [Related]
8. Treatment of antibody-mediated rejection after kidney transplantation.
Sureshkumar KK; Oti IU; Baroody SC; Hussain SM; Carpenter BJ; Nghiem DD; Marcus RJ
Transplant Proc; 2008 Jun; 40(5):1373-4. PubMed ID: 18589109
[No Abstract] [Full Text] [Related]
9. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation.
Cherikh WS; Kauffman HM; McBride MA; Maghirang J; Swinnen LJ; Hanto DW
Transplantation; 2003 Nov; 76(9):1289-93. PubMed ID: 14627905
[TBL] [Abstract][Full Text] [Related]
10. Treatment of steroid resistant acute rejection after renal transplantation.
Oh CK; Kim YS; Kim MS; Kim SI; Park K
Transplant Proc; 1996 Jun; 28(3):1453-4. PubMed ID: 8658737
[No Abstract] [Full Text] [Related]
11. The use of OKT3 rescue therapy after orthotopic liver transplantation--the University of Nebraska Medical Center experience.
Wood RP; Shaw BW; Williams L
Transplant Proc; 1988 Feb; 20(1 Suppl 1):254-9. PubMed ID: 3279616
[No Abstract] [Full Text] [Related]
12. Evaluation of monocyte procoagulant activity as a parameter for immunologic monitoring in renal transplantation.
Zappala SM; Khauli RB; Miller-Graziano C; Takayama TK; Stoff JS; Menon M
Transplant Proc; 1989 Feb; 21(1 Pt 2):1844-5. PubMed ID: 2652600
[No Abstract] [Full Text] [Related]
13. Immunologic monitoring of antithymocyte globulin treatment for acute allograft rejection.
Delmonico FL; Nelson PW; Colvin RB; Cosimi AB
Transplant Proc; 1984 Dec; 16(6):1492-3. PubMed ID: 6390852
[No Abstract] [Full Text] [Related]
14. The role of antilymphocyte globulin in cadaver renal transplantation.
Novick AC
Transplant Proc; 1986 Jun; 18(3 Suppl 2):22-7. PubMed ID: 3521000
[No Abstract] [Full Text] [Related]
15. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
Cantarovich D
J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acute rejection crisis by antilymphocyte globulins: a randomized prospective study in pediatric kidney transplantation.
Broyer M; Niaudet P; Bijaoui M; Gagnadoux MF
Transplant Proc; 1987 Feb; 19(1 Pt 3):1886-8. PubMed ID: 3547894
[No Abstract] [Full Text] [Related]
17. Presumptive serum sickness as a complication of rabbit-derived antithymocyte globulin immunosuppression.
Snow MH; Cannella AC; Stevens RB; Mikuls TR
Arthritis Rheum; 2009 Sep; 61(9):1271-4. PubMed ID: 19714613
[No Abstract] [Full Text] [Related]
18. Preliminary results of a randomized comparison of cyclosporine and Minnesota Antilymphoblast Globulin.
Halloran PF; Lien J; Aprile M; White N
Transplant Proc; 1982 Dec; 14(4):627-30. PubMed ID: 6301117
[No Abstract] [Full Text] [Related]
19. Antithymocyte globulin as the primary treatment for renal allograft rejection.
Nelson PW; Cosimi AB; Delmonico FL; Rubin RH; Tolkoff-Rubin NE; Fang L; Russell PS
Transplantation; 1983 Nov; 36(5):587-9. PubMed ID: 6356523
[No Abstract] [Full Text] [Related]
20. The influence of the immunosuppressants OKT3 and ATG on immunological parameters.
Neumann MC; Müller TF; Sprenger H; Gemsa D; Lange H
Clin Nephrol; 1996 May; 45(5):345-8. PubMed ID: 8738669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
